Variant report

Variant	nsv1011725
Chromosome Location	chr3:21786893-21804428
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:286)
CpG islands
(count:610)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:286 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:21792431-21793017	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr3:21792339-21792940	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr3:21792005-21792065	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr3:21792482-21792673	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr3:21792301-21793038	H1-hESC	embryonic stem cell:	n/a	n/a
6	CREB1	chr3:21792463-21792984	H1-hESC	embryonic stem cell:	n/a	n/a
7	CREB1	chr3:21792360-21793085	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr3:21792388-21792991	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr3:21794337-21794564	GM12878	blood:	n/a	n/a
10	CTCF	chr3:21794360-21794510	HVMF	connective:	n/a	n/a
11	CTCF	chr3:21794314-21794535	HepG2	liver:	n/a	n/a
12	CTCF	chr3:21794400-21794550	K562	blood:	n/a	n/a
13	CTCF	chr3:21794360-21794510	Caco-2	colon:	n/a	n/a
14	CTCF	chr3:21794314-21794570	Lung_OC	lung:	n/a	n/a
15	CTCF	chr3:21794440-21794590	HCT-116	colon:	n/a	n/a
16	CTCF	chr3:21794317-21794560	ProgFib	skin:	n/a	n/a
17	CTCF	chr3:21793980-21794130	AG10803	skin:	n/a	n/a
18	CTCF	chr3:21794340-21794490	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr3:21794367-21794499	NHEK	skin:	n/a	n/a
20	CTCF	chr3:21793220-21793370	HMEC	breast:	n/a	n/a
21	CTCF	chr3:21794340-21794490	NHLF	lung:	n/a	n/a
22	CTCF	chr3:21794346-21794521	Pancreas_OC	pancreas:	n/a	n/a
23	CTCF	chr3:21794380-21794530	AG09319	gingival:	n/a	n/a
24	CTCF	chr3:21794360-21794510	HCM	heart:	n/a	n/a
25	CTCF	chr3:21794400-21794550	AG04450	lung:	n/a	n/a
26	CTCF	chr3:21794280-21794430	A549	lung:	n/a	n/a
27	CTCF	chr3:21794400-21794550	MCF-7	breast:	n/a	n/a
28	CTCF	chr3:21794380-21794530	GM12865	blood:	n/a	n/a
29	CTCF	chr3:21792400-21792550	BJ	skin:	n/a	n/a
30	CTCF	chr3:21794268-21794661	IMR90	lung:	n/a	n/a
31	CTCF	chr3:21794357-21794551	GM13977	blood:	n/a	n/a
32	CTCF	chr3:21794368-21794519	GM10248	blood:	n/a	n/a
33	CTCF	chr3:21793840-21793990	HMF	breast:	n/a	n/a
34	CTCF	chr3:21794400-21794550	AG09309	skin:	n/a	n/a
35	CTCF	chr3:21794247-21794629	GM12878	blood:	n/a	n/a
36	CTCF	chr3:21794380-21794530	HA-sp	spinal cord:	n/a	n/a
37	CTCF	chr3:21794340-21794490	SK-N-SH_RA	brain:	n/a	n/a
38	CTCF	chr3:21794521-21794522	GM10248	blood:	n/a	n/a
39	CTCF	chr3:21794340-21794490	GM12867	blood:	n/a	n/a
40	CTCF	chr3:21794360-21794510	HCPEpiC	choroid plexus:	n/a	n/a
41	CTCF	chr3:21792520-21792670	AG04449	skin:	n/a	n/a
42	CTCF	chr3:21794360-21794510	SAEC	small airway:	n/a	n/a
43	CTCF	chr3:21794320-21794470	GM12866	blood:	n/a	n/a
44	CTCF	chr3:21794291-21794623	Medullo	brain:	n/a	n/a
45	CTCF	chr3:21801600-21801750	NHLF	lung:	n/a	n/a
46	CTCF	chr3:21794380-21794530	Caco-2	colon:	n/a	n/a
47	CTCF	chr3:21794372-21794508	GM13976	blood:	n/a	n/a
48	CTCF	chr3:21794360-21794510	WERI-Rb-1	eye:	n/a	n/a
49	CTCF	chr3:21794340-21794490	GM06990	blood:	n/a	n/a
50	CTCF	chr3:21794423-21794440	MCF-7	breast:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:21792543-21792593	CMK	blood:	n/a
2	chr3:21793557-21793607	U87	brain:	n/a
3	chr3:21792991-21793041	HCM	heart:	n/a
4	chr3:21792857-21792907	ProgFib	skin:	n/a
5	chr3:21792684-21792734	HRPEpiC	eye:	n/a
6	chr3:21792543-21792593	HCM	heart:	n/a
7	chr3:21792543-21792593	AG10803	skin:	n/a
8	chr3:21792543-21792593	PrEC	prostate:	n/a
9	chr3:21792857-21792907	HCPEpiC	choroid plexus:	n/a
10	chr3:21792248-21792298	AG09309	skin:	n/a
11	chr3:21793557-21793607	HCM	heart:	n/a
12	chr3:21792684-21792734	NT2-D1	testis:	n/a
13	chr3:21792991-21793041	LNCaP	prostate:	n/a
14	chr3:21790232-21790282	HRCEpiC	kidney:	n/a
15	chr3:21793557-21793607	BJ	skin:	n/a
16	chr3:21792965-21793015	T-47D	breast:	n/a
17	chr3:21792991-21793041	HMEC	breast:	n/a
18	chr3:21792434-21792484	LNCaP	prostate:	n/a
19	chr3:21792543-21792593	HRCEpiC	kidney:	n/a
20	chr3:21793557-21793607	AG04450	lung:	fetal
21	chr3:21790232-21790282	HRPEpiC	eye:	n/a
22	chr3:21792684-21792734	HIPEpiC	eye:	n/a
23	chr3:21793557-21793607	NHDF-neo	bronchial:	n/a
24	chr3:21792248-21792298	HEEpiC	esophagus:	n/a
25	chr3:21792684-21792734	PFSK-1	brain:	n/a
26	chr3:21793557-21793607	ovcar-3	ovarian:	n/a
27	chr3:21792684-21792734	K562	blood:	n/a
28	chr3:21792857-21792907	GM12878	blood:	n/a
29	chr3:21793557-21793607	Hela-S3	cervix:	n/a
30	chr3:21792938-21792988	SAEC	small airway:	n/a
31	chr3:21792965-21793015	GM12891	blood:	n/a
32	chr3:21792434-21792484	BJ	skin:	n/a
33	chr3:21792543-21792593	AG04449	skin:	fetal
34	chr3:21792684-21792734	AG04450	lung:	fetal
35	chr3:21792965-21793015	HMEC	breast:	n/a
36	chr3:21792684-21792734	BE2_C	brain:	n/a
37	chr3:21792938-21792988	NT2-D1	testis:	n/a
38	chr3:21793557-21793607	HUVEC	blood vessel:	n/a
39	chr3:21792991-21793041	IMR90	lung:	fetal
40	chr3:21792684-21792734	AoSMC	blood vessel:	n/a
41	chr3:21792991-21793041	HEEpiC	esophagus:	n/a
42	chr3:21792938-21792988	H1-hESC	embryonic stem cell:	embryo
43	chr3:21792434-21792484	ovcar-3	ovarian:	n/a
44	chr3:21792434-21792484	AG09319	gingival:	n/a
45	chr3:21792857-21792907	HRE	kidney:	n/a
46	chr3:21792938-21792988	AG04449	skin:	fetal
47	chr3:21792434-21792484	HEK293	kidney:	embryo
48	chr3:21792857-21792907	NHBE	bronchial:	n/a
49	chr3:21792938-21792988	SK-N-MC	brain:	n/a
50	chr3:21792857-21792907	HCT-116	colon:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:21793963..21794585-chr3:21876272..21877179,2	MCF-7	breast:
2	chr3:21794398..21795153-chr3:22159350..22159975,2	MCF-7	breast:
3	chr3:21793981..21794891-chr3:21935742..21936689,4	MCF-7	breast:

No data

Variant related genes	Relation type
ZNF385D	TF binding region
ZNF385D	CpG island

Extended variants
information (count: 832 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:832 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6798573	chr3:21786893-21786894	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs558104047	chr3:21786904-21786905	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs573283047	chr3:21786928-21786929	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs533987404	chr3:21786953-21786954	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs555448096	chr3:21786956-21786957	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs147714455	chr3:21786958-21786959	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs534716987	chr3:21786980-21786981	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs76509454	chr3:21787026-21787027	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs555191693	chr3:21787035-21787036	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs575189279	chr3:21787042-21787043	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs545967352	chr3:21787092-21787093	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs13078263	chr3:21787133-21787134	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs537715512	chr3:21787185-21787186	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs12494689	chr3:21787230-21787231	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs546338167	chr3:21787231-21787232	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs540266814	chr3:21787393-21787394	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs372447165	chr3:21787403-21787404	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs146797179	chr3:21787418-21787419	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs192768694	chr3:21787497-21787498	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs550626040	chr3:21787499-21787500	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs377674382	chr3:21787512-21787513	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs4146796	chr3:21787514-21787515	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs139306613	chr3:21787530-21787531	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs545466916	chr3:21787553-21787554	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs183146019	chr3:21787560-21787561	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs534417513	chr3:21787598-21787599	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs370785657	chr3:21787615-21787616	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs149008059	chr3:21787621-21787622	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs555411353	chr3:21787630-21787631	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs13078866	chr3:21787653-21787654	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs187462833	chr3:21787657-21787658	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs537833848	chr3:21787690-21787691	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs556177172	chr3:21787697-21787698	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs531363891	chr3:21787722-21787723	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs55967962	chr3:21787740-21787741	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs191899792	chr3:21787748-21787749	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs184747850	chr3:21787765-21787766	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs189487981	chr3:21787776-21787777	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs148204104	chr3:21787784-21787785	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs540455884	chr3:21787785-21787786	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs76642688	chr3:21787789-21787790	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs529035138	chr3:21787794-21787795	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs544220394	chr3:21787827-21787828	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs562418939	chr3:21787855-21787856	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs532950246	chr3:21787919-21787920	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs527575610	chr3:21787947-21787948	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs193251813	chr3:21787980-21787981	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs141194800	chr3:21787994-21787995	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs116358039	chr3:21788020-21788021	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs549199735	chr3:21788033-21788034	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
lymphocytic leukemia	21291569	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Esophageal cancer	20955586	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Squamous cell cancer	20885788	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Breast cancer	17133270	CNVD
Developmental delay	21147756	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Melanoma	20688739	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:374 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:21776600-21788800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr3:21778200-21787800	Weak transcription	Fetal Stomach	stomach
3	chr3:21778200-21791400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr3:21780600-21791400	Weak transcription	Fetal Heart	heart
5	chr3:21781000-21788600	Weak transcription	Right Ventricle	heart
6	chr3:21781000-21788800	Weak transcription	Left Ventricle	heart
7	chr3:21784200-21790600	Weak transcription	Fetal Muscle Trunk	muscle
8	chr3:21785600-21787000	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr3:21786000-21787000	Enhancers	Fetal Muscle Leg	muscle
10	chr3:21786400-21787000	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr3:21786400-21787000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr3:21786400-21787000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr3:21786400-21787800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr3:21786400-21788000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr3:21786400-21789600	Enhancers	Fetal Kidney	kidney
16	chr3:21786400-21789800	Enhancers	NH-A	brain
17	chr3:21786400-21793600	Active TSS	Aorta	Aorta
18	chr3:21786600-21787000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr3:21786600-21787200	Enhancers	Fetal Brain Male	brain
20	chr3:21786600-21788600	Weak transcription	Right Atrium	heart
21	chr3:21786600-21790000	Enhancers	Fetal Lung	lung
22	chr3:21786800-21787000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr3:21786800-21787000	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr3:21786800-21787000	Enhancers	HSMMtube	muscle
25	chr3:21786800-21787000	Flanking Active TSS	NHDF-Ad	bronchial
26	chr3:21786800-21787200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr3:21786800-21788400	Enhancers	Muscle Satellite Cultured Cells	--
28	chr3:21786800-21788800	Weak transcription	HMEC	breast
29	chr3:21787000-21787200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr3:21787000-21787200	Enhancers	HSMM	muscle
31	chr3:21787000-21788200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr3:21787000-21788200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
33	chr3:21787000-21788200	Weak transcription	HSMMtube	muscle
34	chr3:21787000-21788200	Active TSS	NHDF-Ad	bronchial
35	chr3:21787000-21788800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr3:21787000-21788800	Weak transcription	Fetal Muscle Leg	muscle
37	chr3:21787000-21789000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr3:21787200-21787400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr3:21787200-21787800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr3:21787200-21788800	Enhancers	Pancreatic Islets	Pancreatic Islet
41	chr3:21787200-21789000	Weak transcription	Fetal Brain Male	brain
42	chr3:21787200-21791400	Weak transcription	HSMM	muscle
43	chr3:21787400-21787600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr3:21787400-21789200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr3:21787600-21787800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr3:21787600-21787800	Enhancers	Brain Germinal Matrix	brain
47	chr3:21787800-21788000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr3:21787800-21788400	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr3:21787800-21789400	Enhancers	Fetal Stomach	stomach
50	chr3:21787800-21789600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links